Traditional Chinese medicine composition for treating kidney deficiency type ovarian reserve function decline disease and application thereof

An ovarian reserve and composition technology, which is applied in the field of traditional Chinese medicine compositions for the treatment of kidney deficiency type ovarian reserve dysfunction diseases, can solve the problems of small side effects and significant curative effect, and achieves improvement of traditional Chinese medicine syndrome, increase of antral follicle count, and good clinical curative effect. Effect

CN114366777AInactive Publication Date: 2022-04-19上海市静安区中医医院
2 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2022-04-19
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a traditional Chinese medicine composition for treating kidney deficiency type ovarian reserve function decline diseases. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 10-14 parts of poria cocos, 8-12 parts of radix rehmanniae, 8-12 parts of radix rehmanniae preparata, 8-12 parts of glossy privet fruits, 8-12 parts of rhizoma curculiginis, 8-12 parts of herba epimedii, 8-12 parts of radix morindae officinalis, 8-12 parts of herba cistanche, 8-12 parts of cornu cervi degelatinatum and 28-32 parts of amethyst. The invention further provides application of the traditional Chinese medicine composition. The traditional Chinese medicine composition can effectively improve the endocrine hormone level of a DOR patient, improve the menstruation condition and relieve clinical symptoms, has a good clinical curative effect, is an effective proved recipe for treating the DOR, provides a thought and evidence-based medical evidence for treating the DOR through traditional Chinese medicine, and is worthy of further defining the action mechanism of the traditional Chinese medicine composition for improving the ovarian reserve function subsequently.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating kidney-deficiency type ovarian reserve function decline and its application. Background technique

[0002] The etiology and pathogenesis of decreased ovarian reserve (DOR) are complex. With the increase of social pressure on women, the intensification of environmental pollution, and unhealthy living habits, the incidence of DOR is increasing year by year and showing a trend of younger age. At present, Western medicine mainly focuses on hormone replacement in treatment. Scholars at home and abroad believe that the application of HRT in patients with ovarian function decline can give HPOA a temporary rest and temporarily control the disease. Studies have shown that FSH can be significantly reduced after 3 months of treatment. However, although femotone can reduce the level of FSH, FSH may rebound after...

Examples

Embodiment 1

[0017] Embodiment 1 Chinese medicine composition of the present invention (1)

[0018] Take each raw material medicine by weight ratio: 12 parts of Poria cocos, 10 parts of raw land, 10 parts of Rehmannia glutinosa, 10 parts of Ligustrum lucidum, 10 parts of curculigo, 10 parts of fairy spleen, 10 parts of Morinda officinalis, 10 parts of Cistanche, 10 parts of antler cream, 30 parts of amethyst.

Embodiment 2

[0019] Embodiment 2 Chinese medicine composition of the present invention (two)

[0020] Weigh each raw material according to the weight ratio: 12 parts of Poria cocos, 8 parts of rehmannia, 12 parts of Rehmannia glutinosa, 10 parts of Ligustrum lucidum, 8 parts of curculigo, 12 parts of fairy spleen, 9 parts of Morinda officinalis, 11 parts of Cistanche, 12 parts of antler cream, 29 parts of amethyst.

Embodiment 3

[0021] Embodiment 3 Chinese medicine composition of the present invention (three)

[0022] Weigh each raw material medicine according to weight ratio: 10 parts of Poria cocos, 12 parts of rehmannia glutinosa, 9 parts of Rehmannia glutinosa, 8 parts of Ligustrum lucidum, 12 parts of curculigo, 9 parts of fairy spleen, 11 parts of Morinda officinalis, 10 parts of Cistanche, 9 parts of antler cream, 31 parts of amethyst.